Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor

Circulation

Volumn 94, Issue 12, 1996, Pages 3341-3347

  Bauersachs, Johann ^a   Popp, Rüdiger ^a   Hecker, Markus ^a   Sauer, Edith ^a   Fleming, Ingrid ^a   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

acetylcholine; bradykinin; calcium; endothelium derived factors; vasodilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLCHOLINE; ARACHIDONIC ACID; BRADYKININ; CALCIUM; DICLOFENAC; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GUANYLATE CYCLASE INHIBITOR; ISOPRENALINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE INHIBITOR; TETRABUTYLAMMONIUM;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTERY DILATATION; ARTICLE; CAROTID ARTERY; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SMOOTH MUSCLE FIBER; SWINE;

EID: 0030469546     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3341     Document Type: Article

References (44)

1. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 1995;16:23-30.
2. Cohen RA, Vanhoutte PM. Endolhelium-dependem hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 1995;92: 3337-3349.
3. Rubanyi GM, Vanhoutte PM. Nature of endothelium-derived relaxing factor: arc there two relaxing mediators? Circ Res. 1987;61: 61-67.
4. Rubanyi GM, McKinney M, Vanhoutte PM. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries: characterization of muscarinic receptors. J Pharmacol Exp Ther. 1987;240:802-808.
5. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels. 1990;27:238-245.
6. Hecker M, Bara A, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (Land). 1994;4812:407-414.
7. Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol. 1994:113:1548-1553.
8. + channels in the vasodilator response to bradykinin in the rat heart. Br J Pharmacol. 1994; 113:954-958.
9. Fulton D, Mahboubi K, McGiff JC, Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol. 1995;114:99-102.
10. Lischke V, Busse R, Hecker M. Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br J Pharmacol. 1995;115:969-974.
11. G-nitro-L-arginine in rats. Am J Physiol. 1992;263:H1090-H1094.
12. Nagao T, Vanhoutte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxation in the porcine coronary artery. J Physiol (Lund). 1992;445:355-367.
13. Mombouli J-V, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992;71:137-144.
14. Mombouli J-V, Nakashima M, Hamra M, Vanhoutte PM. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training. Br J Pharmacol. 1996;117:413-118.
15. Kilpatrick EV, Cocks TM. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br J Pharmacol. 1994;112: 557-565.
16. Busse R, Fichtner H, Lückhoff A, Kohlhardt M. Hyperpolarization and increased free calcium in acetylcholine-stimulated endothelial cells. Am J Physiol. 1988;255:H965-H969.
17. Chen G, Suzuki H. Calcium dependency of the endothelium-dependent hyperpolarization in smooth muscle cells of the rabbit carotid artery. J Physiol (Land). 1990;421:521-534.
18. Vedernikov JP, Gräser T, Vanin AF. Similar endothelium-independent arterial relaxation by carbon monoxide and nitric oxide. Biomed Biochim Acta. 1989;48:595-599.
19. Busse R, Lamomagne D. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:126-129.
20. Schini VB, Catovsky B, Schray-Utz B, Busse R, Vanhoutte PM. Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Circ Res. 1994;74:24-32.
21. Busse R, Pohl U, Kellner C, Klemm U. Endothelial cells are involved in the vasodilatory response to hypoxia. Pflugers Arch. 1983;397: 78-80.
22. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988;92: 145-159.
23. Hamill OP, Marty A, Neher E, Sakman B, Sigworth FJ. Improved patch clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391: 85-100.
24. Lamontagne D, König A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol. 1992;20:652-657.
25. Fleming I, Hecker M, Busse R. Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ Res. 1994;74:1220-1226.
26. Mülsch A, Hecker M, Mordvintcev PI, Vanin AF, Busse R. Enzymic and nonenzymic release of NO accounts for the vasodilator activity of the metabolites of CAS 936, a novel long-acting sydnonimine derivative. Naunyn Schmiedebergs Arch Pharmacol. 1993;347:92-100.
27. Hecker M, Vorhoff W, Bara A, Mordvintcev PI, Busse R. Characterization of furoxans as a new class of tolerance-resistant nitro-vasodilators. Naunyn Schmiedebergs Arch Pharmacol. 1995;351: 426-432.
28. Nakashima M, Mombouli J-V, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 1993;92:2867-2871.
29. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
30. Parkington HC, Tare M, Tonta MA, Coleman HA. Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J Physiol (Lond). 1993;465: 459-476.
31. Taylor SG, Southerton JS, Weston AH, Baker JRJ. Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalin. Br J Pharmacol. 1988;94: 853-863.
32. Rand VE, Garland CJ. Endothelium-dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane hyper-polarization. Br J Pharmacol. 1992;106:143-150.
33. Komori K, Lorenz RR, Vanhoutte PM, Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol. 1988;255:143-150.
34. 2+ channels. Br J Pharmacol. 1996;117:1035-1040.
35. Illiano S, Nagao T, Vanhoutte PM. Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery. Br J Pharmacol. 1992; 107:387-392.
36. Weintraub NL, Stephenson AH, Sprague RS, McMurdo L, Lonigro AJ. Relationship of arachidonic acid release to porcine coronary artery relaxation. Hypertension. 1995;26:684-690.
37. 2+ of endothelial cells and vascular smooth muscle cells. J Biol Chem. 1992;267: 20377-20382.
38. Parsaee H, McEwan JR, Joseph S, MacDermot J. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathway to cytosolic calcium in bovine aortic endothelial cells. Br J Pharmacol. 1992;107:1013-1019.
39. Garg CG, Hassid A. Nitric oxide decreases cytosolic free calcium in Balb/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. J Biol Chem. 1991;266:9-12.
40. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA. 1993;90: 11147-11151.
41. Busse R, Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res. 1996;33:181-194.
42. Najibi S, Cowan CL, Palacino JJ, Cohen RA. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol. 1994;266:H2061-H2067.
43. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acids. Ear J Pharmacol. 1993;230:215-221.
44. Pfister SL, Falck JR, Campbell WB. Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am J Physiol. 1991:261:H843-H852.